Jim Cramer says Eli Lilly's obesity pill could be more of a 'lifetime drug' than shots

Jim Cramer says Eli Lilly's obesity pill could be more of a 'lifetime drug' than shots

"Persistence is the enemy of these [GLP-1 drugs] right now," CNBC's Jim Cramer said Wednesday.

Jim Cramer says Eli Lilly’s obesity pill could be more of a ‘lifetime drug’ than shots – DG Verifications & Stats

Don’t count out Eli Lilly’s oral GLP-1 drug for obesity and diabetes just yet, according to CNBC’s Jim Cramer . That was his takeaway following the latest study involving Lilly’s orforglipron, the experimental pill that has been the subject of Wall Street debate since weight-loss data released in early August came in below investor expectations. The stock tumbled 14% in a single day as investors feared that their expectations for orforglipron sa…